Lexaria Bioscience Releases Second Episode of Investor Video Series
Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innovator in oral drug delivery platforms, today released the second episode of Reformulated: Into the Mainstream, the Company's ongoing investor communications series.The latest episode features CEO Rich Christopher in conversation with host Ana Berry. The discussion covers the recently announced extension of Lexaria's Material Transfer Agreement with a global...
Read more








